在COVID-19相关的肺栓塞发生一年后,对右心室功能的影响
Federica Ilardi1, Mario Crisci2, Cecilia Calabrese3
1Department of Advanced Biomedical Sciences, Federico II University Hospital, Via S. Pansini, 5, 80131 Naples, Italy.
Journal of clinical medicine
|June 10, 2023
概括
肺栓塞 (PE) 病史的康复COVID-19患者在感染后一年内表现出持续的亚临床右心室 (RV) 功能障碍. 损伤的RV自由壁纵向拉伸 (RV-FWLS) 低于21%是这种功能障碍的关键指标,与PE相关.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 冠状病毒疾病2019 (COVID-19) 可能导致肺栓塞 (PE),这是一个严重的并发症.
- COVID-19的长期心脏影响,特别是亚临床功能障碍,需要进一步调查.
研究的目的:
- 在康复的COVID-19患者中评估亚临床心脏功能障碍,有或没有PE病史.
- 在COVID-19后的患者中确定可预测PE的心声学标志物.
主要方法:
- 在44名康复的COVID-19患者 (22名有PE,22名没有PE) 上进行了跨胸腔心声扫描.
- 测量包括右心室全球纵向应变 (RV-GLS) 和RV自由壁纵向应变 (RV-FWLS).
- 统计分析,包括ROC曲线和多变量后勤回归,用于确定PE的预测因素.
主要成果:
- 与没有PE (PE-) 的患者相比,患有PE (PE+) 的患者表现出显著减少的RV-GLS和RV-FWLS.
- 确定RV-FWLS<21%是预测PE的最佳切断值 (灵敏度74%,特异性89%).
- 减少RV-FWLS (<21%) 在这个队列中独立与PE和肥胖有关.
结论:
- 亚临床右心室功能障碍在COVID-19后的一年内,在有PE病史的患者中持续存在.
- 损坏的RV-GLS和RV-FWLS是这种持续性功能障碍的关键指标.
- RV-FWLS <21%是COVID相关PE的显著独立预测因素.
更多相关视频
相关概念视频
Mitral Stenosis I: Introduction
18
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Pulmonary Embolism I: Introduction
10
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Mitral Regurgitation I: Introduction
19
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
Cardiac Catheterization II: Right Heart Catheterization
57
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
57
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12


